Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block for Prevention of Postoperative Atrial Fibrillation
NCT07893275Phase 3Not yet recruiting
- Sponsor
- Cleveland Clinic
- Start
- Oct 2026
- Primary completion
- Oct 2027
01
Overview
A Phase 3 trial of bupivacaine in Atrial fibrillation (AFib), sponsored by Cleveland Clinic. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07893275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07893275.